溢多利（300381）变更回购股份用途、注销股份及减少注册资本公告详解

公告要点

• 回购股份用途发生重大变更：原用于“员工持股计划或股权激励”的10,887,600股回购股份，现变更为“用于减少注册资本”，并将予以注销。
• 注册资本及总股本减少：注销完成后，公司总股本由491,061,461股降至480,173,861股，注册资本相应减少。
• 公司章程修订：公司同步修订注册资本、股份总数及经营范围条款。
• 经营范围进一步规范与扩展：新增和细化了生物饲料、生物基材料、工业酶制剂等研发、生产、销售等业务，强化技术服务等内容。
• 变更原因：因回购股份36个月未转让，依据相关法律法规必须进行注销，体现公司规范运作。

详细解读

回购股份情况

溢多利于2022年5月17日董事会审议通过股份回购方案，计划以自有资金通过集中竞价方式回购A股，用于员工持股或股权激励。回购资金总额为1亿元至2亿元，回购价格不超12.50元/股。2022年5月21日因分红调整回购上限至12.40元/股。回购实际执行时间为2022年5月31日至2023年5月9日，共回购10,887,600股，占当时总股本2.22%，成交总金额1.001亿元，最高价10.74元/股，最低价8.14元/股。

回购用途变更及注销原因

根据公司法、上市公司回购规则及深交所指引，回购股份须在36个月内用于员工持股或股权激励，未能转让则需注销并减少注册资本。此次回购股份已达36个月期限且未使用，公司决定将用途变更为“用于注销并减少注册资本”，以维护投资者利益并增强市场信心。

股本变动及公司章程修订

• 股本变化：注销后总股本由491,061,461股减至480,173,861股。
• 股本结构：有限售条件流通股和无限售条件流通股比例略有调整，股份总数减少。
• 章程修订：注册资本、股份总数相应修改，经营范围新增和细化生物饲料、工业酶制剂、生物基材料等研发生产销售内容，技术服务、工程和技术研究等业务领域扩展，明确许可项目与一般项目。

对公司的影响

此次变更系公司依据法律规定做出的审慎决策，不影响公司债务履行能力、持续经营及股东权益，不会导致控股股东或实际控制人变化，也不会对财务状况及经营成果产生重大影响。公司利益及中小股东权益不会受损。

对投资者和股价影响提示

• 股份注销及注册资本减少：意味着公司每股收益理论上有提升空间（总股本减少），可能对公司估值和股价带来正面影响。
• 未实施员工持股或股权激励：可能导致市场对公司激励机制及员工团队稳定性的重新评估。
• 经营范围扩展：显示公司业务升级和转型，或引发市场对新业务成长性的关注。
• 合规性与规范运作：公司严格按法律法规处理未转让股份，增强投资者信心。

结论

本公告涉及股份注销、注册资本减少、章程修订及经营范围调整，属于重大公司治理事项，可能对公司估值、股价结构及市场信心产生实质影响，值得投资者重点关注。

免责声明：本文仅为信息披露解读，不构成任何投资建议。投资者应结合自身风险偏好，审慎决策。公司公告原文及相关法律法规为最终解释依据。

English Version:

YiduoLi (300381): Major Changes in Repurchased Shares Use, Share Cancellation, and Capital Reduction

Key Points of the Announcement

• Major Change in Repurchased Shares Use: 10,887,600 shares repurchased originally for “employee shareholding plan or equity incentive” are now to be used for “reducing registered capital” and will be cancelled.
• Reduction in Registered Capital and Total Shares: After cancellation, total shares will decrease from 491,061,461 to 480,173,861, with registered capital reduced accordingly.
• Company Articles Revised: Simultaneous revisions to registered capital, total shares, and business scope clauses.
• Business Scope Expanded and Standardized: Expanded to include R&D, manufacture, and sales of biological feed, biobased materials, industrial enzyme preparations, technical services, and more.
• Reason for Change: Repurchased shares not transferred within 36 months, per regulations, must be cancelled, reflecting compliance and standardized operation.

Detailed Analysis

Repurchase Details

YiduoLi’s board approved a share repurchase plan on May 17, 2022, using own funds via centralized bidding, intended for employee incentives. Total funds: RMB 100-200 million, price cap: RMB 12.50/share (adjusted to RMB 12.40/share after dividend). Repurchase executed from May 31, 2022 to May 9, 2023: 10,887,600 shares repurchased (2.22% of total at that time), total transaction RMB 100.1 million, highest price RMB 10.74/share, lowest RMB 8.14/share.

Repurchase Use Change & Cancellation Reason

Per Company Law, repurchase rules, and SZSE guidance, repurchased shares must be transferred within 36 months for employee incentives; otherwise, they must be cancelled and capital reduced. Since these shares have not been transferred and are approaching 36 months, the company opts to cancel them to protect investor interests and market confidence.

Share Structure & Articles Amendment

• Share Changes: Total shares drop from 491,061,461 to 480,173,861 after cancellation.
• Structure: Minor adjustments in restricted and unrestricted shares, overall reduction in total shares.
• Articles Revision: Registered capital, total shares, business scope updated—expansion into biological feed, industrial enzymes, biobased materials, technical services, engineering R&D, and more, with clear distinction of permitted items.

Impact on Company

This change is a prudent, legal-compliant decision, with no impact on debt fulfillment, ongoing operations, or shareholder rights, nor on controlling shareholders or financial position. No damage to company or minority shareholders.

Investor & Share Price Sensitivity

• Share Cancellation & Capital Reduction: Fewer shares may boost per-share earnings, potentially affecting valuation and share price positively.
• No Employee Incentive Implementation: May prompt reassessment of company incentive mechanisms and staff stability.
• Business Scope Expansion: Indicates business upgrade/transition, may spark market attention to growth prospects.
• Compliance & Standardized Operation: Lawful handling of unused repurchased shares enhances investor confidence.

Conclusion

This announcement covers share cancellation, capital reduction, articles amendment, and business scope revision—a significant corporate governance matter that could impact valuation, share structure, and market confidence. Investors should pay close attention.

Disclaimer: This article is for information interpretation only and does not constitute investment advice. Investors should make careful decisions based on their risk preferences. The original company announcement and relevant laws are the final reference.

View 溢多利 Historical chart here